The Vanderbilt Center for Cognitive Medicine conducts research and clinical activities that focus on disorders of cognition (memory, thinking, and learning). A major focus is on the aging brain, including normal and abnormal cognitive aging. The Center studies the causes and treatment of late-life cognitive disorders, including Mild Cognitive Impairment (MCI), Alzheimer’s disease, and cognitive impairment secondary to other disorders such as cancer, HIV, Down syndrome, and depression. Our Center is committed to searching for answers that will lead to the improvement of the lives of those who suffer from memory loss. Our focus ranges from early Phase 1 development of new molecules for cognitive enhancement, Phase 2 biomarker and imaging investigations and proof of concept studies to Phase 3 pivotal trials. Our center works with many internal and external collaborators including the Vanderbilt Center for Neuroscience Drug Discovery on novel drug development for Alzheimer’s disease and other centers outside Vanderbilt on clinical trials in cognitive disorders including the Alzheimer’s Therapeutic Research Institute at the University of Southern California, and a number of commercial partners.
Paul A. Newhouse, M.DDirector of CCM
Be a citizen scientist and help preserve
millions of memories for generations to come.
Thousands of research volunteers are needed now.JOIN NOW